

| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.4M | +81.4% |
| Cost of Revenue | $3.1M | +106.3% |
| Gross Profit | $5.3M | +69.4% |
| R&D Expense | $5.0M | +31.8% |
| SG&A Expense | $27.0M | +32.2% |
| Operating Income | -$132.2M | -117.6% |
| Interest Expense | $972K | -36.6% |
| Pre-tax Income | -$68.0M | +0.0% |
| Income Tax | $618K |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $139.7M | +180.2% |
| Accounts Receivable | $1.5M | +8.1% |
| Inventory | $5.6M | -3.9% |
| Current Assets | $151.0M | +159.2% |
| Total Assets | $260.5M | +69.7% |
| Current Liabilities | $17.4M | -57.0% |
| Total Liabilities | $58.0M | -53.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$115.7M | -142.0% |
| Capital Expenditures | $8.5M | +113.1% |
| Investing Cash Flow | -$48.4M | -113.8% |
| Financing Cash Flow | $254.4M | +129.2% |
| Free Cash Flow | -$124.2M | -139.7% |
| +27.7% |
| Net Income | -$160.2M | -133.9% |
| EPS (Basic) | $1.91 | +99.0% |
| EPS (Diluted) | $1.91 | +99.0% |
| Stockholders' Equity |
| $206.4M |
| +840.9% |